Bogart Wealth LLC Sells 173 Shares of iShares Biotechnology ETF $IBB

Bogart Wealth LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 39.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 261 shares of the financial services provider’s stock after selling 173 shares during the period. Bogart Wealth LLC’s holdings in iShares Biotechnology ETF were worth $33,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in IBB. Signet Financial Management LLC boosted its holdings in iShares Biotechnology ETF by 3.3% during the 2nd quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock valued at $326,000 after acquiring an additional 83 shares during the period. Apollon Wealth Management LLC lifted its position in iShares Biotechnology ETF by 1.1% in the first quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock valued at $1,120,000 after purchasing an additional 96 shares during the last quarter. SBI Securities Co. Ltd. lifted its holdings in iShares Biotechnology ETF by 5.2% in the first quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock worth $281,000 after buying an additional 108 shares during the period. KFG Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 4.8% in the 2nd quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after acquiring an additional 112 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its stake in shares of iShares Biotechnology ETF by 5.3% in the 2nd quarter. QRG Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock valued at $308,000 after purchasing an additional 123 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $156.03 on Wednesday. The company’s fifty day moving average price is $143.87 and its 200-day moving average price is $131.94. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $157.19.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.